Keith Edwards Appointed Chief Executive Officer Of N2 Biomedical
News provided by
Share this article
Share this article
BEDFORD, Mass., June 29, 2021 /PRNewswire/ -- N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, is pleased to announce that Keith Edwards has been appointed Chief Executive Officer. Mr. Edwards will assume leadership of all aspects of the organization and will oversee the implementation of N2's growth strategy.
Mr. Edwards brings a wealth of expertise to this role, with more than 20 years of experience within the medical device industry and a particular focus on the orthopedic market. Most recently, he served as SVP & General Manager of Hamilton Thorne, Ltd., and prior to this role, served as President & CEO of Biocoat, Inc. Preceding his role at Biocoat, Mr. Edwards served in numerous senior management positions within Biomet Orthopedics during his five-year tenure. He is a graduate of Union College and attended New York Medical College.